drugset / Trial / NCT02255604

Effect of Intralymphatic Immunotherapy

NCT02255604 ↗

Phase 2 Completed 36 enrolled University of Aarhus
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators want to investigate whether specific immunotherapy can be delivered directly into a lymph node. The investigators think that a direct introduction of allergen to the antigen presenting cells in the lymph node a give a strong immune response and that this can change the number of injections needed in allergen immunotherapy. The investigators do measurements of clinical effect and a variety of paraclinical test to see if the investigators can find af biomarker of successful specific immune therapy of grass allergy.

Timeline

Start
2013-08
Primary completion
2015-09
Completion
2017-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alk (225) Phleum Pratense Unknown 0.1 ml Other

Indications